RNase1 enables cancer cells to prevent CD8+ T‐cell attacks through signal transducer and activator of transcription 1 (STAT1) inactivation, causing T‐cell dysfunction and underscoring RNase1's immunosuppressive role. This evidence concerns the gene CD8A and cancer.